{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,6,12]],"date-time":"2026-06-12T11:29:43Z","timestamp":1781263783312,"version":"3.54.1"},"reference-count":20,"publisher":"Elsevier BV","issue":"11","license":[{"start":{"date-parts":[[2018,11,1]],"date-time":"2018-11-01T00:00:00Z","timestamp":1541030400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"}],"content-domain":{"domain":["clinicalkey.jp","clinicalkey.com","jamda.com","clinicalkey.es","clinicalkey.fr","clinicalkey.com.au","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Journal of the American Medical Directors Association"],"published-print":{"date-parts":[[2018,11]]},"DOI":"10.1016\/j.jamda.2018.06.023","type":"journal-article","created":{"date-parts":[[2018,8,9]],"date-time":"2018-08-09T10:24:25Z","timestamp":1533810265000},"page":"1009-1014","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":18,"title":["Discontinuation of Long-Term Antipsychotic Drug Use for Behavioral and Psychological Symptoms in Older Adults Aged 65\u00a0Years and Older With Dementia"],"prefix":"10.1016","volume":"19","author":[{"given":"Ellen","family":"Van Leeuwen","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mirko","family":"Petrovic","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mieke L.","family":"van Driel","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"An IM","family":"De Sutter","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Robert Vander","family":"Stichele","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Tom","family":"Declercq","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Thierry","family":"Christiaens","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.jamda.2018.06.023_bib1","doi-asserted-by":"crossref","first-page":"114","DOI":"10.4088\/JCP.v65n0120","article-title":"A\u00a03-month, randomized, placebo-controlled, neuroleptic discontinuation study in 100 people with dementia: The Neuropsychiatric Inventory median cut-off is a predictor of clinical outcome","volume":"65","author":"Ballard","year":"2004","journal-title":"J\u00a0Clin Psychiatry"},{"key":"10.1016\/j.jamda.2018.06.023_bib2","doi-asserted-by":"crossref","first-page":"e76","DOI":"10.1371\/journal.pmed.0050076","article-title":"A\u00a0randomised, blinded, placebo-controlled trial in dementia patients continuing or stopping neuroleptics (the DART-AD trial)","volume":"5","author":"Ballard","year":"2008","journal-title":"PLoS Med"},{"key":"10.1016\/j.jamda.2018.06.023_bib3","author":"Bergh"},{"key":"10.1016\/j.jamda.2018.06.023_bib4","doi-asserted-by":"crossref","first-page":"119","DOI":"10.1177\/089198879701000306","article-title":"Withdrawal of neuroleptic medications from institutionalized dementia patients: Results of a double-blind, baseline-treatment-controlled pilot study","volume":"10","author":"Bridges-Parlet","year":"1997","journal-title":"J\u00a0Geriatr Psychiatry Neurol"},{"key":"10.1016\/j.jamda.2018.06.023_bib5","doi-asserted-by":"crossref","first-page":"937","DOI":"10.1002\/gps.2630","article-title":"A\u00a06-month, randomized, double-blind, placebo-controlled pilot discontinuation trial following response to haloperidol treatment of psychosis and agitation in Alzheimer's disease","volume":"26","author":"Devanand","year":"2011","journal-title":"Int J Geriatr Psychiatry"},{"key":"10.1016\/j.jamda.2018.06.023_bib6","doi-asserted-by":"crossref","first-page":"1497","DOI":"10.1056\/NEJMoa1114058","article-title":"Relapse risk after discontinuation of risperidone in Alzheimer's disease","volume":"367","author":"Devanand","year":"2012","journal-title":"N\u00a0Engl J Med"},{"key":"10.1016\/j.jamda.2018.06.023_bib7","doi-asserted-by":"crossref","first-page":"115","DOI":"10.1002\/gps.930040210","article-title":"Double-blind controlled withdrawal of thioridazine treatments in elderly female inpatients with senile dementia","volume":"4","author":"Findlay","year":"1989","journal-title":"Int J Geriatr Psychiatry"},{"key":"10.1016\/j.jamda.2018.06.023_bib8","doi-asserted-by":"crossref","first-page":"889","DOI":"10.1002\/gps.1998","article-title":"Stopping antipsychotic drug therapy in demented nursing home patients: A randomized, placebo-controlled study - the Bergen District Nursing Home Study (BEDNURS)","volume":"23","author":"Ruths","year":"2008","journal-title":"Int J Geriatr Psychiatry"},{"key":"10.1016\/j.jamda.2018.06.023_bib9","doi-asserted-by":"crossref","first-page":"197","DOI":"10.1017\/S1041610202008396","article-title":"A\u00a0randomized, placebo-controlled trial of the discontinuation of long-term antipsychotics in dementia","volume":"14","author":"van Reekum","year":"2002","journal-title":"Int Psychogeriatr"},{"key":"10.1016\/j.jamda.2018.06.023_bib10","doi-asserted-by":"crossref","first-page":"2673","DOI":"10.1016\/S0140-6736(17)31363-6","article-title":"Dementia prevention, intervention, and care","volume":"390","author":"Livingston","year":"2017","journal-title":"Lancet"},{"key":"10.1016\/j.jamda.2018.06.023_bib11","first-page":"CD007726","article-title":"Withdrawal versus continuation of long-term antipsychotic drug use for behavioural and psychological symptoms in older people with dementia","volume":"3","author":"Van Leeuwen","year":"2018","journal-title":"Cochrane Database Syst Rev"},{"key":"10.1016\/j.jamda.2018.06.023_bib12","series-title":"Cochrane Handbook for Systematic Reviews of Interventions\u00a0Version 5.2.0 [updated June 2017]","year":"2017"},{"key":"10.1016\/j.jamda.2018.06.023_bib13","unstructured":"GRADEpro GDT (Computer Program). McMaster University (developed by Evidence\u00a0Prime). Version accessed 1 July 2017. Mc Master University: Hamilton,\u00a0ON."},{"key":"10.1016\/j.jamda.2018.06.023_bib14","doi-asserted-by":"crossref","first-page":"1733","DOI":"10.1001\/archinte.159.15.1733","article-title":"Withdrawal of haloperidol, thioridazine, and lorazepam in the nursing home","volume":"159","author":"Cohen-Mansfield","year":"1999","journal-title":"Arch Intern Med"},{"key":"10.1016\/j.jamda.2018.06.023_bib15","unstructured":"National Institute for Health and Clinical Excellence. Dementia: Supporting people with dementia and their carers in health and social care. Available at: Guidance.nice.org.uk\/CG42. Accessed September 8,\u00a02017."},{"key":"10.1016\/j.jamda.2018.06.023_bib16","first-page":"17","article-title":"Deprescribing antipsychotics for behavioural and psychological symptoms of dementia and insomnia: Evidence-based clinical practice guideline","volume":"64","author":"Bjerre","year":"2018","journal-title":"Can Fam Phys"},{"key":"10.1016\/j.jamda.2018.06.023_bib17","doi-asserted-by":"crossref","first-page":"109","DOI":"10.1097\/JCP.0b013e3182a6096e","article-title":"Use and safety of antipsychotics in behavioral disorders in elderly people with dementia","volume":"34","author":"Gareri","year":"2014","journal-title":"J\u00a0Clin Psychopharmacol"},{"key":"10.1016\/j.jamda.2018.06.023_bib18","doi-asserted-by":"crossref","first-page":"915","DOI":"10.3233\/JAD-140579","article-title":"The efficacy and safety of atypical antipsychotics for the treatment of dementia: A meta-analysis of randomized placebo-controlled trials","volume":"42","author":"Ma","year":"2014","journal-title":"J\u00a0Alzheimers Dis"},{"key":"10.1016\/j.jamda.2018.06.023_bib19","doi-asserted-by":"crossref","first-page":"1849","DOI":"10.1017\/S1041610215000745","article-title":"A\u00a0consensus guideline for antipsychotic drug use for dementia in care homes. Bridging the gap between scientific evidence and clinical practice","volume":"27","author":"Zuidema","year":"2015","journal-title":"International Psychogeriatrics"},{"key":"10.1016\/j.jamda.2018.06.023_bib20","doi-asserted-by":"crossref","first-page":"390","DOI":"10.5694\/mja14.00146","article-title":"First do no harm: A real need to deprescribe in older patients","volume":"20","author":"Scott","year":"2014","journal-title":"Med J Aust"}],"container-title":["Journal of the American Medical Directors Association"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S152586101830361X?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S152586101830361X?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2018,10,25]],"date-time":"2018-10-25T20:24:16Z","timestamp":1540499056000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S152586101830361X"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2018,11]]},"references-count":20,"journal-issue":{"issue":"11","published-print":{"date-parts":[[2018,11]]}},"alternative-id":["S152586101830361X"],"URL":"https:\/\/doi.org\/10.1016\/j.jamda.2018.06.023","relation":{},"ISSN":["1525-8610"],"issn-type":[{"value":"1525-8610","type":"print"}],"subject":[],"published":{"date-parts":[[2018,11]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Discontinuation of Long-Term Antipsychotic Drug Use for Behavioral and Psychological Symptoms in Older Adults Aged 65\u00a0Years and Older With Dementia","name":"articletitle","label":"Article Title"},{"value":"Journal of the American Medical Directors Association","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.jamda.2018.06.023","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2018 AMDA - The Society for Post-Acute and Long-Term Care Medicine.","name":"copyright","label":"Copyright"}]}}